Intuitive Surgical Gets FDA OK for Latest Robotic System
By Ben Glickman
Intuitive Surgical said Thursday it received approval from U.S. regulators for its latest robotic system for surgery, the da Vinci 5.
The Sunnyvale, Calif.-based company said the U.S. Food and Drug Administration cleared its 510(k) form, allowing Intuitive to bring its product to market.
The company's new multiport robotic system will first be available to a small number of customers in the U.S. who worked with the company during development. Intuitive said it would generate additional data on the system before a wider commercial rollout.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
March 14, 2024 17:02 ET (21:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations